193 related articles for article (PubMed ID: 36077467)
1. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase.
Yang MH; Li WY; Wu CF; Lee YC; Chen AY; Tyan YC; Chen YA
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077467
[TBL] [Abstract][Full Text] [Related]
2. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
[TBL] [Abstract][Full Text] [Related]
4. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
Borowa-Mazgaj B; de Conti A; Tryndyak V; Steward CR; Jimenez L; Melnyk S; Seneshaw M; Mirshahi F; Rusyn I; Beland FA; Sanyal AJ; Pogribny IP
Toxicol Sci; 2019 Aug; 170(2):273-282. PubMed ID: 31086990
[TBL] [Abstract][Full Text] [Related]
6. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.
Pacana T; Cazanave S; Verdianelli A; Patel V; Min HK; Mirshahi F; Quinlivan E; Sanyal AJ
PLoS One; 2015; 10(8):e0136822. PubMed ID: 26322888
[TBL] [Abstract][Full Text] [Related]
8. Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.
Liao YJ; Chen TL; Lee TS; Wang HA; Wang CK; Liao LY; Liu RS; Huang SF; Chen YM
Mol Med; 2012 May; 18(1):412-22. PubMed ID: 22183894
[TBL] [Abstract][Full Text] [Related]
9. Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
Kant R; Yen CH; Lu CK; Lin YC; Li JH; Chen YM
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153064
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
Quinn C; Rico MC; Merali C; Merali S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216100
[TBL] [Abstract][Full Text] [Related]
11. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
12. The combination of metformin with morin alleviates hepatic steatosis via modulating hepatic lipid metabolism, hepatic inflammation, brown adipose tissue thermogenesis, and white adipose tissue browning in high-fat diet-fed mice.
Tehrani SS; Goodarzi G; Panahi G; Zamani-Garmsiri F; Meshkani R
Life Sci; 2023 Jun; 323():121706. PubMed ID: 37075944
[TBL] [Abstract][Full Text] [Related]
13. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
[TBL] [Abstract][Full Text] [Related]
14. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice.
Zamani-Garmsiri F; Hashemnia SMR; Shabani M; Bagherieh M; Emamgholipour S; Meshkani R
J Nutr Biochem; 2021 Jan; 87():108505. PubMed ID: 32956824
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin.
Stachowicz A; Suski M; Olszanecki R; Madej J; Okoń K; Korbut R
J Proteomics; 2012 Dec; 77():167-75. PubMed ID: 22960565
[TBL] [Abstract][Full Text] [Related]
16. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
[TBL] [Abstract][Full Text] [Related]
17. Targeted and untargeted metabolomics provide insight into the consequences of glycine-N-methyltransferase deficiency including the novel finding of defective immune function.
Eudy BJ; McDermott CE; Liu X; da Silva RP
Physiol Rep; 2020 Sep; 8(18):e14576. PubMed ID: 32951289
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice.
Goodarzi G; Tehrani SS; Panahi G; Bahramzadeh A; Meshkani R
J Nutr Biochem; 2023 Aug; 118():109369. PubMed ID: 37100305
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
20. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.
Malik AN; Simões ICM; Rosa HS; Khan S; Karkucinska-Wieckowska A; Wieckowski MR
Cells; 2019 Oct; 8(10):. PubMed ID: 31597406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
